Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Ion Agirrezabal, Luiz Sérgio Pereira Grillo Junior, Felipe Nasser, Victoria K. Brennan, Diogo Bugano, Francisco Leonardo Galastri, André Luis F. de Azeredo- da-Silva, Suki Shergill & Joaquim Maurício da Motta-Leal-Filho. (2023) Cost-effectiveness of selective internal radiation therapy with Y-90 resin microspheres for intermediate- and advanced-stage hepatocellular carcinoma in Brazil. Journal of Medical Economics 26:1, pages 731-741.
Read now
Read now
Siu Hing Lo, Rohini Sharma, Charlotte E Costentin, Daniel Aggio, Suki Shergill, Fabien Colaone, Victoria K Brennan, Vincenzo A Straccia, Ion Agirrezabal & Andrew J Lloyd. (2021) Patient Preferences for Advanced Hepatocellular Carcinoma Treatment: A Multicountry Stated Preference Study. Future Oncology 17:32, pages 4275-4287.
Read now
Read now
Noemi Muszbek, Edit Remak, Rachel Evans, Victoria K Brennan, Fabien Colaone, Suki Shergill, Damian Mullan & Paul J Ross. (2021) Cost–Utility Analysis of Selective Internal Radiation Therapy with Y-90 Resin Microspheres in Hepatocellular Carcinoma. Future Oncology 17:9, pages 1055-1068.
Read now
Read now
Articles from other publishers (22)
Shukui Qin, Weijia Fang, Zhenggang Ren, Shuangyan Ou, Ho Yeong Lim, Feng Zhang, Kin Chung Lee, Hye Jin Choi, Jiandong Tong, Min Tao, Aibing Xu, Ashley Cheng, Chang-Hsien Lu, Chang-Fang Chiu, Mohamed Ibrahim Abdul Wahid, Shital Kamble, Josephine M. Norquist, Wenyan Zhong, Chen Li & Zhendong Chen. (2024) A Phase 3 Study of Pembrolizumab versus Placebo for Previously Treated Patients from Asia with Hepatocellular Carcinoma: Health-Related Quality of Life Analysis from KEYNOTE-394. Liver Cancer, pages 1-12.
Crossref
Crossref
M. Saad Malik, Michael W. Subrize, Jiangda Ou, Michael P. Curry, Neehar D. Parikh, Victor Novack, Jeffrey L. Weinstein, Muneeb Ahmed & Ammar Sarwar. (2024) Association between Patient Experience Scores and Low Utilization of Hepatocellular Carcinoma Treatment in the United States: A Surveillance, Epidemiology, and End Results–Consumer Assessment of Healthcare Providers and Systems Analysis (SEER-CAHPS). Journal of Vascular and Interventional Radiology 35:1, pages 102-112.e5.
Crossref
Crossref
Andrew M. Moon, Sarah Cook, Rachel M. Swier, Hanna K. Sanoff, Michael D. Kappelman, Lynne I. Wagner, A. Sidney Barritt, Amit G. Singal, Neil D. Shah, David M. Mauro, Ted K. Yanagihara, David A. Gerber, Michael W. Fried, Cristal Brown, Myra Waheed, Randall Teal & Donna M. Evon. (2023) Patient-reported symptoms and interest in symptom monitoring in HCC treated with locoregional therapies: A qualitative study. Hepatology Communications 7:11.
Crossref
Crossref
Ginny Jacobs, Deborah A. Boyle, Hashem B. El‐Serag, Robert J. Lewandowski, Stacey M. Stein, Patrice Lazure & Pam McFadden. (2022) Clinical care in hepatocellular carcinoma: A mixed methods assessment of experiences and challenges of oncology professionals. Cancer Medicine 12:3, pages 3670-3683.
Crossref
Crossref
Eleanor M. L. Norman, Jennifer Weil & Jennifer Philip. (2022) Hepatocellular carcinoma and its impact on quality of life: A review of the qualitative literature. European Journal of Cancer Care 31:6.
Crossref
Crossref
Marina Serper, Neehar D. Parikh, Grace Thiele, Nadia Ovchinsky, Shivang Mehta, Alexander Kuo, Chanda Ho, Fasiha Kanwal, Michael Volk, Sumeet K. Asrani, Marwan S. Ghabril, John R. Lake, Raphael B. Merriman, Timothy R. Morgan & Elliot B. Tapper. (2022) Patient‐reported outcomes in HCC: A scoping review by the Practice Metrics Committee of the American Association for the Study of Liver Diseases. Hepatology 76:1, pages 251-274.
Crossref
Crossref
Jim (Zhang Hao) Li, Jane McLeod & Paris-Ann Ingledew. (2022) Quality Analysis of Online Patient Resources for Hepatocellular Carcinoma. Journal of Clinical Gastroenterology 56:1, pages 64-71.
Crossref
Crossref
Sydney C. Yuen, Adaeze Q. Amaefule, Hannah H. Kim, Breanna-Verissa Owoo, Emily F. Gorman & T. Joseph MattinglyIIII. (2021) A Systematic Review of Cost-Effectiveness Analyses for Hepatocellular Carcinoma Treatment. PharmacoEconomics - Open 6:1, pages 9-19.
Crossref
Crossref
Vahid Mansouri & Nima Rezaei. 2023. Hepatobiliary Cancers: An Interdisciplinary Approach. Hepatobiliary Cancers: An Interdisciplinary Approach
1
40
.
Helena Pereira, Mohamed Bouattour, Marco D. Burgio, Eric Assenat, Jules Grégory, Jean-Pierre Bronowicki, Gilles Chatellier, Valérie Vilgrain, Eric Assenat, Elisabeth Delhom-Christol, Marjolène Fourcade, Boris Guiu, Alina Diana Ilonca, Julie Lonjon, Georges-Philippe Pageaux, Mohamed Abdel-Rehim, Wassim Allaham, Mohamed Bouattour, Laurent Castera, Arnaud Dieudonné, Rachida Lebtahi, Maxime Ronot, Annie Sibert, Valérie Vilgrain, Hélène Chor, Julie Devictor, Hélène Barraud, Christophe Bazin, Jean-Pierre Bronowicki, Laetitia Imbert, Valérie Laurent, Elodie Mathias, Carine Chagneau-Derrode, Christelle Gallais, Rémy Perdrisot, Christine Silvain, Jean Pierre Tasu, Patrick Borentain, Bardia Farman, René Gerolami, Olivier Mundler, Jean-Francois Seitz, Vincent Vidal, Christophe Aubé, Francis Bouchet, Antoine Bouvier, Olivier Couturier, Frédéric Oberti, Laurent Vervueren, Isabelle Brenot-Rossi, Julien Darreon, Jean Luc Raoul, Anthony Sarran, Julia Chalaye, Charlotte Costentin, Emmanuel Itti, Hicham Kobeiter, Alain Luciani, Hélène Masset, René Adam, Maïté Lewin, Didier Samuel, Julien Edeline, Etienne Garin, Sophie Laffont, Yan Rolland, Isabelle Archambeaud, Thomas Carlier, Thomas Eugene, Eric Frampas, Christophe Cassinotto, Martine Guyot, Jean-Baptiste Hiriart, Bruno Lapuyade, Karine Tendero, Julien Vergniol, Philippe Bachellier, Julien Détour, Bernard Duclos, Michel Greget, Francois Habersetzer, Alessio Imperiale, Elise Enderlin, Philippe Merle, Agnès Rode, Julie Morvan, Eric Nguyen-Khac, Antoine Talbot, Thierry Yzet, Guillaume Baudin, Patrick Chevallier, Abakar Mahamat, Fabien Maurel, Thierry Piche, Micheline Razzouk, Patrick Hillon, Romaric Loffroy, Michel Toubeau, Julie Vincent, Jean-Marc Vrigneaud, Gabriele Barabino, Nadia Bouarioua, Muriel Cuilleron, Marie Ecochard, Nathalie Prevot-Bitot, Evelyne Rousset, Vincent Leroy, Ghislaine Reboulet, Julie Roux, Christian Sengel, Valérie Bourcier, Nathalie Ganne-Carrie, Olivier Seror, Sylvie Costo, Thông Dao, Cédric Desmonts, Jean-Pierre Pelage, Didier Defez, Jérôme Dumortier, Francesco Giammarile, Pierre-Jean Valette, Michela Bernardini, Nadia Ghazar, Olivier Pellerin, Julien Taieb, Pierre Weinmann, Alexandra Heurgue-Berlot, Claude Marcus, Daniele Sommacale, Maria-Angéla Castilla-Lièvre, Aurélie Forbes, Sophie Maitre & Lysiane Marthey. (2021) Health-related quality of life in locally advanced hepatocellular carcinoma treated by either radioembolisation or sorafenib (SARAH trial). European Journal of Cancer 154, pages 46-56.
Crossref
Crossref
Kerstin Wohlleber, Patrick Heger, Pascal Probst, Christoph Engel, Markus K. Diener & André L. Mihaljevic. (2021) Health-related quality of life in primary hepatic cancer: a systematic review assessing the methodological properties of instruments and a meta-analysis comparing treatment strategies. Quality of Life Research 30:9, pages 2429-2466.
Crossref
Crossref
Manisha Verma, James M. Paik, Issah Younossi, Daisong Tan, Hala Abdelaal & Zobair M. Younossi. (2021) The impact of hepatocellular carcinoma diagnosis on patients' health‐related quality of life. Cancer Medicine 10:18, pages 6273-6281.
Crossref
Crossref
Nicola Personeni & Lorenza Rimassa. (2021) Are we ready for patient-reported outcomes in hepatocellular carcinoma?. The Lancet Gastroenterology & Hepatology 6:8, pages 602-603.
Crossref
Crossref
Jenny L. Firkins, Robin Tarter, Martha Driessnack & Lissi Hansen. (2021) A closer look at quality of life in the hepatocellular carcinoma literature. Quality of Life Research 30:6, pages 1525-1535.
Crossref
Crossref
Baek‐Yeol Ryoo, Philippe Merle, Amit S. Kulkarni, Ann‐Lii Cheng, Mohamed Bouattour, Ho Yeong Lim, Valeriy Breder, Julien Edeline, Yee Chao, Sadahisa Ogasawara, Thomas Yau, Marcelo Garrido, Stephen L. Chan, Bruno Daniele, Josephine M. Norquist, Erluo Chen, Abby B. Siegel, Andrew X. Zhu, Richard S. Finn & Masatoshi Kudo. (2020) Health‐related quality‐of‐life impact of pembrolizumab versus best supportive care in previously systemically treated patients with advanced hepatocellular carcinoma: KEYNOTE‐240. Cancer 127:6, pages 865-874.
Crossref
Crossref
Yoon Kim, Jinserk Seo, So-Yeon An, Dong Hyun Sinn & Ji Hye Hwang. (2020) Efficacy and Safety of an mHealth App and Wearable Device in Physical Performance for Patients With Hepatocellular Carcinoma: Development and Usability Study. JMIR mHealth and uHealth 8:3, pages e14435.
Crossref
Crossref
Caren van Roekel, Maarten L. J. Smits, Jip F. Prince, Rutger C. G. Bruijnen, Maurice A. A. J. van den Bosch & Marnix G. E. H. Lam. (2019) Quality of life in patients with liver tumors treated with holmium-166 radioembolization. Clinical & Experimental Metastasis 37:1, pages 95-105.
Crossref
Crossref
Danbee Kang, Sungkeun Shim, Juhee Cho & Hyo Keun Lim. (2020) Systematic Review of Studies Assessing the Health-Related Quality of Life of Hepatocellular Carcinoma Patients from 2009 to 2018. Korean Journal of Radiology 21:6, pages 633.
Crossref
Crossref
In Fun Li, Jen‐Chien Huang, Jyh‐Jou Chen, Tseng En Wang, Sheng‐Shiung Huang & Shiow‐Luan Tsay. (2019) Factors related to the quality of life in liver cancer patients during treatment phase: A follow‐up study. European Journal of Cancer Care 28:6.
Crossref
Crossref
Cyrill Wehling, Daniel Hornuss, Pasquale Schneider, Christoph Springfeld, Katrin Hoffmann, De-Hua Chang, Patrick Naumann, Markus Mieth, Thomas Longerich, Clemens Kratochwil, Arianeb Mehrabi, Annika Gauss, Karl Heinz Weiss & Jan Pfeiffenberger. (2019) Impact of interventions and tumor stage on health-related quality of life in patients with hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology 145:11, pages 2761-2769.
Crossref
Crossref
Daneng Li, Sabrina Sedano, Rebecca Allen, Jun Gong, May Cho & Sunil Sharma. (2019) Current Treatment Landscape for Advanced Hepatocellular Carcinoma: Patient Outcomes and the Impact on Quality of Life. Cancers 11:6, pages 841.
Crossref
Crossref
Brian C. Grieb, Laura W. Goff, Lipika Goyal & Crystal S. Denlinger. (2019) Evolving Landscape of Systemic Therapy for Hepatocellular Carcinoma: Breakthroughs, Toxicities, and Future Frontiers. American Society of Clinical Oncology Educational Book:39, pages 248-260.
Crossref
Crossref